| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/01/2003 | CA2464372A1 Functional heavy chain antibodies, fragments thereof, library thereof and methods of production thereof |
| 05/01/2003 | CA2464344A1 Ee3-protein family and corresponding dna sequences |
| 05/01/2003 | CA2464111A1 Phosphonic acid compounds as inhibitors of serine proteases |
| 05/01/2003 | CA2464085A1 A combination product comprising melagatran and dexamethasone |
| 05/01/2003 | CA2463311A1 Androgen receptor modulators and methods of use thereof |
| 05/01/2003 | CA2463101A1 Azole derivatives and pharmaceutical compositions containing them |
| 05/01/2003 | CA2461181A1 Use of potent, selective and non-toxic c-kit inhibitors for treating bacterial infections |
| 05/01/2003 | CA2458958A1 Method and apparatus for dispensing inhalator medicament |
| 05/01/2003 | CA2458542A1 Enzyme inhibitors for inactivating allergens |
| 05/01/2003 | CA2454361A1 Humanized antibodies |
| 04/30/2003 | CN1414965A Sulfonamides and derivatives thereof that modulate the activeity of endothelin |
| 04/30/2003 | CN1414961A Substituted oximes and hydrazones as neurokinin antagonists |
| 04/30/2003 | CN1414960A Substituted piperidines, medicaments containing these compounds, and methods for production thereof |
| 04/30/2003 | CN1414950A Substituted pyrrole Mannich bases to treating paint and allergic reactions |
| 04/30/2003 | CN1413729A Glossy ganoderma spore bee-glue buccal tablets for throat discomfort |
| 04/30/2003 | CN1413715A Chinese drugs for treating chronic rhinitis |
| 04/30/2003 | CN1413708A Capsule for releiving cough and its preparation technology |
| 04/30/2003 | CN1413699A Drug for treating bronchial disease |
| 04/30/2003 | CN1413693A Drug for treating cold |
| 04/30/2003 | CN1413692A Medicin spray for treating throat disease and stomatopathy |
| 04/30/2003 | CN1413691A Drug for treating cough |
| 04/30/2003 | CN1413686A Medicine for treating respiratory tract system disease caused by cold |
| 04/30/2003 | CN1413685A Medicine for treating throat disease and stomatopathy |
| 04/30/2003 | CN1413665A Momordica charantia powder lozenge and its preparation technology |
| 04/30/2003 | CN1413654A Chinese medicine pill for treating cough |
| 04/30/2003 | CN1413643A Method for extracting chrysanthemum medicinal component and extract |
| 04/30/2003 | CN1413597A Method for treatment of injury and rhinitis bleeding |
| 04/30/2003 | CN1107061C Chemotaxis cell factor receptor-3 receptor antagonists |
| 04/30/2003 | CN1107058C Subsitituted isoxazoles for treatment of inflammation |
| 04/30/2003 | CN1106852C Medicine for treating cough and its preparation process |
| 04/29/2003 | US6555710 Aminobenzophenones as inhibitors of IL-1 β and TNF-α |
| 04/29/2003 | US6555700 1,3-propane diol esters and ethers and methods for their use in drug delivery |
| 04/29/2003 | US6555689 Intermediates useful for the preparation of antihistaminic piperidine derivatives |
| 04/29/2003 | US6555583 Therapies for treating pulmonary diseases |
| 04/29/2003 | US6555566 Methods and materials for treating and preventing inflammation of mucosal tissue |
| 04/29/2003 | US6555557 2,3-disubstituted pyridine derivatives, process for the preparation thereof, drug compositions containing the same and intermediates for the preparation |
| 04/29/2003 | US6555543 Inhibiting the effects of platelet activating factor (PAF). |
| 04/29/2003 | US6555542 Sulfonamide lactam inhibitors of FXa and method |
| 04/29/2003 | US6555541 Substituted phenyl compounds with immunosuppressing activity and pharmaceutical compositions |
| 04/29/2003 | US6555518 2',2'-difluoronucleosides for suppressing rejection of transplants in mammals; for treatment of autoimmune diseases |
| 04/29/2003 | US6555377 Process for production of mammalian cell lines |
| 04/29/2003 | US6555352 Peptide for use in human therapeutics and diagnostic compositions |
| 04/29/2003 | CA2103571C Method of treating pulmonary inflammation |
| 04/29/2003 | CA2078028C A tramadol n-oxide material, enantiomers and compositions thereof, and their use |
| 04/26/2003 | CA2409084A1 Anti-inflammatory agent and foods and drinks containing the same |
| 04/24/2003 | WO2003033528A1 Cyclic peptides as g-protein-coupled receptor antagonists |
| 04/24/2003 | WO2003033527A2 Cyclosporine analogue mixtures and their use as immunomodulating agents |
| 04/24/2003 | WO2003033502A1 Bicyclic oxopyridine and oxopyrimidine derivatives |
| 04/24/2003 | WO2003033501A1 Himbacine analogues as thrombin receptor antagonists |
| 04/24/2003 | WO2003033495A1 Quinuclidine derivatives, processes for preparing them and their uses as m2 and/or m3 muscarinic receptor inhibitors |
| 04/24/2003 | WO2003033486A1 Novel substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 04/24/2003 | WO2003033483A1 Biphenylcarboxylic amide derivatives as p38 kinase inhibitors |
| 04/24/2003 | WO2003033482A1 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors |
| 04/24/2003 | WO2003033472A1 Quinoline or quinazoline derivatives inhibiting auto- phosphorylation of fibroblast growth factor receptors |
| 04/24/2003 | WO2003033466A1 Aralkyl-tetrahydro-pyridines, their preparation and pharmaceutical compositions containing same |
| 04/24/2003 | WO2003033457A1 Biphenyl-derivatives as p38-kinase inhibitors |
| 04/24/2003 | WO2003033014A2 Novel use of pulmonary surfactant |
| 04/24/2003 | WO2003033010A1 Cyclosporin analogs for the treatment of autoimmune diseases |
| 04/24/2003 | WO2003033002A1 Intracellular calcium concentration increase inhibitors |
| 04/24/2003 | WO2003033000A1 Pharmaceutical combinations comprising salmeterol and fluticasone proprionate for the treatment of asthma |
| 04/24/2003 | WO2003032999A1 Alkyne matrix metalloproteinase inhibitors |
| 04/24/2003 | WO2003032991A1 N-aroyl piperazine derivatives as orexin receptor antagonists |
| 04/24/2003 | WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors |
| 04/24/2003 | WO2003032987A1 2'-methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032986A1 2' -methyl-5-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032980A1 5'-carbamoyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032971A1 5’-acylamino-1,1’-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032970A1 5'-carbamoyl-2'-methyl-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/24/2003 | WO2003032966A1 Compositions for potentiating glutatthione |
| 04/24/2003 | WO2003032964A2 Gap junctions and endothelial-derived hyperpolarizing factor (edhf) |
| 04/24/2003 | WO2003032928A2 Therapeutic composition and use |
| 04/24/2003 | WO2003032918A2 Treatment of infectious disease using interleukin-1 beta converting enzyme (ice)/ced-3 family inhibitors |
| 04/24/2003 | WO2003032894A2 Method of monitoring neuroprotective treatment |
| 04/24/2003 | WO2003032753A1 Use of cystathionine |
| 04/24/2003 | WO2002098907A3 Cation conducting gabaa receptors and their use |
| 04/24/2003 | WO2002085921A3 Simple method for the synthesis of boswellic acids and derivatives thereof |
| 04/24/2003 | WO2002069979A3 Pharmaceutical formulation comprising r-salmeterol and fluticasone propionate |
| 04/24/2003 | WO2002068406A3 Substituted amine derivatives and their use for the treatment of angiogenesis |
| 04/24/2003 | WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | WO2002046383A3 Protein modification and maintenance molecules |
| 04/24/2003 | WO2002043786B1 Uses for medical devices having a lubricious, nitric oxide-releasing coating for the therapy of vascular disorders |
| 04/24/2003 | WO2002026825A3 G-protein coupled receptors |
| 04/24/2003 | US20030078438 N-heterocyclicamide compounds; used as anticoagulant agent |
| 04/24/2003 | US20030078419 For therapy of autoimmune diseases mediated by cathepsin S; for inhibiting the progression of tissue transplant rejection |
| 04/24/2003 | US20030078409 Nucleotide sequences coding polypeptide for use in the treatment of respiratory system, asthmatic and inflammatory bowel diseases |
| 04/24/2003 | US20030078299 Anti-cancer nitro- and thia-fatty acids |
| 04/24/2003 | US20030078294 For therapy of emphysema and/or bronchopulmonary dysplasia in a mammal |
| 04/24/2003 | US20030078288 Indole derivatives |
| 04/24/2003 | US20030078280 Macroheterocylic compounds useful as kinase inhibitors |
| 04/24/2003 | US20030078279 For therapy and prophylaxis of pain, central nervous system disorder or the like in mammalian subjects |
| 04/24/2003 | US20030078278 Spiropiperidine compounds as ligands for ORL-1 receptor |
| 04/24/2003 | US20030078277 For therapy and prophylaxis of depression; Tourette syndrome, autism, bipolar disorder, cyclothymia, schizophrenia, Alzheimer disease, obesity, diabetes, alcohol dependence, sleep disorder, insomnia, migraine, stress headache, etc. |
| 04/24/2003 | US20030078276 Matrix metalloproteinase inhibitors |
| 04/24/2003 | US20030078275 For therapy of cancer, diabetes and Alzheimer's disease |
| 04/24/2003 | US20030078270 Methods of providing and using compounds having activity as inhibitors of cytochrome P450RAI |
| 04/24/2003 | US20030078265 Inhibitors of nitric oxide synthase (nos) |
| 04/24/2003 | US20030078246 Combinations for the treatment of inflammatory disorders |
| 04/24/2003 | US20030078166 Pyrazole compounds useful as protein kinase inhibitors |
| 04/24/2003 | US20030077802 Human PRL1 phosphatase |